{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:52:00Z","timestamp":1783021920150,"version":"3.54.6"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T00:00:00Z","timestamp":1685836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T00:00:00Z","timestamp":1685836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-023-02652-z","type":"journal-article","created":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T08:01:18Z","timestamp":1685865678000},"page":"2561-2569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Dupilumab-associated mycosis fungoides: a cross-sectional study"],"prefix":"10.1007","volume":"315","author":[{"given":"Austin","family":"Hamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Clark","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Alhatem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,4]]},"reference":[{"issue":"3","key":"2652_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.det.2017.02.005","volume":"35","author":"JI Silverberg","year":"2017","unstructured":"Silverberg JI, Kantor R (2017) The role of interleukins 4 and\/or 13 in the pathophysiology and treatment of atopic dermatitis. Dermatol Clin 35(3):327\u2013334","journal-title":"Dermatol Clin"},{"issue":"4","key":"2652_CR2","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1590\/abd1806-4841.20187106","volume":"93","author":"GM Amorim","year":"2018","unstructured":"Amorim GM, Niemeyer-Corbellini JP, Quintella DC, Cuzzi T, Ramos-E-Silva M (2018) Clinical and epidemiological profile of patients with early stage mycosis fungoides. An Bras Dermatol 93(4):546\u2013552","journal-title":"An Bras Dermatol"},{"key":"2652_CR3","doi-asserted-by":"publisher","first-page":"9717530","DOI":"10.1155\/2016\/9717530","volume":"2016","author":"I Saulite","year":"2016","unstructured":"Saulite I, Hoetzenecker W, Weidinger S, Cozzio A, Guenova E, Wehkamp U (2016) S\u00e9zary syndrome and atopic dermatitis: comparison of immunological aspects and targets. Biomed Res Int 2016:9717530","journal-title":"Biomed Res Int"},{"issue":"1S","key":"2652_CR4","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1097\/DER.0000000000000679","volume":"32","author":"M Ayasse","year":"2021","unstructured":"Ayasse M, Nelson K, Glass F, Silverberg JI (2021) Mycosis fungoides unmasked by dupilumab treatment in a patient with a history of atopic dermatitis. Dermatitis 32(1S):e88\u2013e89","journal-title":"Dermatitis"},{"issue":"1","key":"2652_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jaad.2020.03.050","volume":"83","author":"ML Espinosa","year":"2020","unstructured":"Espinosa ML, Nguyen MT, Aguirre AS et al (2020) Progression of cutaneous T-cell lymphoma after dupilumab: case review of 7 patients. J Am Acad Dermatol 83(1):197\u2013199","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2652_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijwd.2016.11.006","volume":"3","author":"A Kelati","year":"2017","unstructured":"Kelati A, Gallouj S, Tahiri L, Harmouche T, Mernissi FZ (2017) Defining the mimics and clinico-histological diagnosis criteria for mycosis fungoides to minimize misdiagnosis. Int J Womens Dermatol 3(2):100\u2013106","journal-title":"Int J Womens Dermatol"},{"issue":"16","key":"2652_CR7","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","volume":"133","author":"R Willemze","year":"2019","unstructured":"Willemze R, Cerroni L, Kempf W et al (2019) The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 133(16):1703\u20131714","journal-title":"Blood"},{"key":"2652_CR8","unstructured":"IBM Corp. Released 2020. IBM SPSS Statistics for windows, version 27.0. Armonk, NY: IBM Corp."},{"issue":"9","key":"2652_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.2340\/00015555-3208","volume":"99","author":"T Chiba","year":"2019","unstructured":"Chiba T, Nagai T, Osada SI, Manabe M (2019) Diagnosis of mycosis fungoides following administration of dupilumab for misdiagnosed atopic dermatitis. Acta Derm Venereol 99(9):818\u2013819","journal-title":"Acta Derm Venereol"},{"key":"2652_CR10","doi-asserted-by":"crossref","unstructured":"Newsom M, Hrin ML, Hamid RN, et al. (2021) Two cases of mycosis fungoides diagnosed after treatment non-response to dupilumab. Dermatol Online J. 27(1). https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33560800","DOI":"10.5070\/D3271052041"},{"key":"2652_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jdcr.2020.12.010","volume":"8","author":"K Russomanno","year":"2021","unstructured":"Russomanno K, Carver DeKlotz CM (2021) Acceleration of cutaneous T-cell lymphoma following dupilumab administration. JAAD Case Rep 8:83\u201385","journal-title":"JAAD Case Rep"},{"issue":"6","key":"2652_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13880","volume":"33","author":"D Miyashiro","year":"2020","unstructured":"Miyashiro D, Vivarelli AG, Gon\u00e7alves F, Cury-Martins J, Sanches JA (2020) Progression of mycosis fungoides after treatment with dupilumab: a case report. Dermatol Ther 33(6):e13880","journal-title":"Dermatol Ther"},{"issue":"2","key":"2652_CR13","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.12788\/cutis.0074","volume":"106","author":"LC Hollins","year":"2020","unstructured":"Hollins LC, Wirth P, Fulchiero GJ Jr, Foulke GT (2020) Long-standing dermatitis treated with dupilumab with subsequent progression to cutaneous T-cell lymphoma. Cutis 106(2):E8\u2013E11","journal-title":"Cutis"},{"issue":"10","key":"2652_CR14","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1097\/DAD.0000000000001875","volume":"43","author":"O Sokumbi","year":"2021","unstructured":"Sokumbi O, Shamim H, Davis MDP, Wetter DA, Newman CC, Comfere N (2021) Evolution of Dupilumab-associated cutaneous atypical lymphoid infiltrates. Am J Dermatopathol 43(10):714\u2013720","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"2652_CR15","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.abd.2020.12.007","volume":"96","author":"JA Sanches","year":"2021","unstructured":"Sanches JA, Cury-Martins J, Abreu RM, Miyashiro D, Pereira J (2021) Mycosis fungoides and s\u00e9zary syndrome: focus on the current treatment scenario. An Bras Dermatol 96(4):458\u2013471","journal-title":"An Bras Dermatol"},{"issue":"7","key":"2652_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ad.2018.03.006","volume":"109","author":"Y Pe\u00f1ate","year":"2018","unstructured":"Pe\u00f1ate Y, Servitje O, Machan S et al (2018) The first year of the AEVD primary cutaneous lymphoma registry. Actas Dermosifiliogr 109(7):610\u2013616","journal-title":"Actas Dermosifiliogr"},{"issue":"3","key":"2652_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.cll.2017.06.006","volume":"37","author":"M Pulitzer","year":"2017","unstructured":"Pulitzer M (2017) Cutaneous T-cell lymphoma. Clin Lab Med. 37(3):527\u2013546","journal-title":"Clin Lab Med."},{"issue":"21","key":"2652_CR18","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","volume":"113","author":"PT Bradford","year":"2009","unstructured":"Bradford PT, Devesa SS, Anderson WF, Toro JR (2009) Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 113(21):5064\u20135073","journal-title":"Blood"},{"issue":"3\u20134","key":"2652_CR19","first-page":"211","volume":"28","author":"WC Lambert","year":"1997","unstructured":"Lambert WC, Cohen PJ, Schwartz RA (1997) Surgical management of mycosis fungoides. J Med 28(3\u20134):211\u2013222","journal-title":"J Med"},{"key":"2652_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081931","author":"N Garc\u00eda-D\u00edaz","year":"2021","unstructured":"Garc\u00eda-D\u00edaz N, Piris M\u00c1, Ortiz-Romero PL, Vaqu\u00e9 JP (2021) Mycosis fungoides and s\u00e9zary syndrome: an integrative review of the pathophysiology, molecular drivers, and targeted therapy. Cancers. https:\/\/doi.org\/10.3390\/cancers13081931","journal-title":"Cancers."},{"issue":"3 Suppl 1","key":"2652_CR21","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.jaad.2017.12.022","volume":"78","author":"MJ Gooderham","year":"2018","unstructured":"Gooderham MJ, Hong HCH, Eshtiaghi P, Papp KA (2018) Dupilumab: a review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol 78(3 Suppl 1):S28\u2013S36","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2652_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","volume":"54","author":"UR Hengge","year":"2006","unstructured":"Hengge UR, Ruzicka T, Schwartz RA, Cork MJ (2006) Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 54(1):1\u201315 (quiz 16-18)","journal-title":"J Am Acad Dermatol."},{"key":"2652_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/children6120133","author":"CH Na","year":"2019","unstructured":"Na CH, Chung J, Simpson EL (2019) Quality of life and disease impact of atopic dermatitis and psoriasis on children and their families. Children. https:\/\/doi.org\/10.3390\/children6120133","journal-title":"Children."},{"issue":"3","key":"2652_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.12788\/cutis.0066","volume":"106","author":"NK Mollanazar","year":"2020","unstructured":"Mollanazar NK, Savage KT, Pousti BT et al (2020) Cutaneous T-cell lymphoma and concomitant atopic dermatitis responding to dupilumab. Cutis 106(3):131\u2013132","journal-title":"Cutis"},{"issue":"16","key":"2652_CR25","doi-asserted-by":"publisher","first-page":"adv00271","DOI":"10.2340\/00015555-3576","volume":"100","author":"I Lazaridou","year":"2020","unstructured":"Lazaridou I, Ram-Wolff C, Bouaziz JD et al (2020) Dupilumab treatment in two patients with cutaneous T-cell lymphomas. Acta Derm Venereol. 100(16):adv00271","journal-title":"Acta Derm Venereol."},{"issue":"18","key":"2652_CR26","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1182\/blood-2014-07-590398","volume":"125","author":"LJ Geskin","year":"2015","unstructured":"Geskin LJ, Viragova S, Stolz DB, Fuschiotti P (2015) Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation. Blood 125(18):2798\u20132805","journal-title":"Blood"},{"issue":"7","key":"2652_CR27","first-page":"949","volume":"137","author":"G Burg","year":"2001","unstructured":"Burg G, Dummer R, Haeffner A, Kempf W, Kadin M (2001) From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol 137(7):949\u2013952","journal-title":"Arch Dermatol"},{"key":"2652_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-022-03330-y","author":"K Nakazaki","year":"2022","unstructured":"Nakazaki K, Yoshida M, Masamoto Y et al (2022) Discordant lymphomas of classic hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis. Int J Hematol. https:\/\/doi.org\/10.1007\/s12185-022-03330-y","journal-title":"Int J Hematol."},{"issue":"3","key":"2652_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15290","volume":"35","author":"M Amagai","year":"2022","unstructured":"Amagai M, Ozawa M, Amagai R et al (2022) Nodal anaplastic large cell lymphoma with lymphomatoid papulosis following treatment of initially presumed atopic dermatitis with dupilumab: a case report. Dermatol Ther 35(3):e15290","journal-title":"Dermatol Ther"},{"issue":"6","key":"2652_CR30","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"E Olsen","year":"2007","unstructured":"Olsen E, Vonderheid E, Pimpinelli N et al (2007) Revisions to the staging and classification of mycosis fungoides and sezary syndrome: a proposal of the international society for cutaneous lymphomas (ISCL) and the cutaneous lymphoma task force of the European organization of research and treatment of cancer (EORTC). Blood 110(6):1713\u20131722","journal-title":"Blood"},{"key":"2652_CR31","doi-asserted-by":"crossref","unstructured":"Smith GL, Wilson LD, Dabaja BS (2016) Chapter 79 Mycosis Fungoides. In: Gunderson LL, Tepper JE (eds) Clinical radiation oncology (Fourth Edition), 4th edn. Elsevier, pp 1556-1576.e4","DOI":"10.1016\/B978-0-323-24098-7.00079-4"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02652-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02652-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02652-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T08:04:50Z","timestamp":1695283490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02652-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,4]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["2652"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02652-z","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,4]]},"assertion":[{"value":"24 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval status"}}]}}